Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)

被引：1

作者：

Rufer, Axel ^{[1
]}

Angermann, Hubert ^{[2
]}

Benz, Rudolf ^{[3
]}

Bonadies, Nicolas ^{[4
,5
]}

Calderoni, Antonello ^{[6
]}

Cantoni, Nathan ^{[7
]}

Efthymiou, Anna ^{[8
]}

Escher, Robert ^{[9
]}

Favre, Genevieve ^{[10
]}

Friess, Dorothea ^{[11
]}

Gschwend, Andreas ^{[12
]}

Himmelmann, Andreas ^{[13
]}

Holbro, Andreas ^{[14
]}

Keller, Peter ^{[15
]}

Kouroupi, Eirini ^{[16
]}

Lehmann, Thomas ^{[17
]}

Pedarnig, Nikolaus ^{[18
]}

Rigamonti, Veronique

Samii, Kaveh ^{[19
]}

Schmidt, Adrian ^{[20
]}

Schafer, Hans-Peter ^{[21
]}

Sperb, Roland ^{[22
]}

Stussi, Georg ^{[23
]}

Winkler, Annette ^{[24
]}

Zenhausern, Reinhard ^{[25
]}

Goede, Jeroen S. ^{[26
]}

机构：

[1] Luzerner Kantonsspital, Dept Hematol, Luzern, Switzerland

[2] Unidata Geodesign GmbH, Vienna, Austria

[3] Kantonsspital Munsterlingen, Oncol Hematol, Munsterlingen, Switzerland

[4] Inselspital Bern, Dept Hematol, Bern, Switzerland

[5] Inselspital Bern, Cent Hematol Lab, Bern, Switzerland

[6] Oncol Verini Calderoni Christinat, Lugano, Switzerland

[7] Kantonsspital Aarau AG, Div Hematol, Univ Clin Med, Aarau, Switzerland

[8] HFR Hop Fribourgeois, Dept Hematooncol, Fribourg, Switzerland

[9] Spital Emmental, Dept Med, Hematol, Burgdorf, Switzerland

[10] Kantonsspital Baselland, Hematol Oncol Immunotherapy, Liestal, Switzerland

[11] Kantonsspital Olten, Dept Hematol, Olten, Switzerland

[12] Zuger Kantonsspital, Oncol Hematol, Baar, Switzerland

[13] Klin St Anna, Hematol, Luzern, Switzerland

[14] Univ Hosp Basel, Dept Hematol, Basel, Switzerland

[15] Spital Langenthal, Hematol Oncol, Langenthal, Switzerland

[16] Hop Neuchatelois, Dept Oncol Hematol, Neuchatel, Switzerland

[17] Kantonsspital St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland

[18] Unidata Geodesign GmbH, Vienna, Austria

[19] Hop Univ Geneve, Serv Hematol, Geneva, Switzerland

[20] Municipal Hosp Zurich Triemli, Clin Med Oncol & Hematol, Dept Internal Med, Zurich, Switzerland

[21] Kantonsspital Schaffhausen, Dept Internal Med, Schaffhausen, Switzerland

[22] Luzerner Kantonsspital, Oncol, Dept Med, Sursee, Switzerland

[23] Osped Reg Bellinzona & Valli, Ist Oncol Svizzera Italiana, Bellinzona, Switzerland

[24] Spital Thun, Ctr Oncol Thun Berner Oberland, Thun, Switzerland

[25] Spitalzentrum Oberwallis, Oncol Hematol, Brig, Switzerland

[26] Kantonsspital Winterthur, Med Oncol & Hematol, Winterthur, Switzerland

来源：

HEMASPHERE | 2022年 / 6卷 / 07期

关键词：

MYELODYSPLASTIC SYNDROMES; DIAGNOSIS;

D O I：

10.1097/HS9.0000000000000741

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 8 条

[1]

[Anonymous], 2022, MYEL SYNDR VERS 2

[2]

Cadenas FL., 2020, ORAL PRESENTATION 62

[3] Myelodysplastic Syndromes [J].

Cazzola, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14) :1358-1374

[4] Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Fenaux, P. ;

Haase, D. ;

Santini, V ;

Sanz, G. F. ;

Platzbecker, U. ;

Mey, U. .

ANNALS OF ONCOLOGY, 2021, 32 (02) :142-156

[5] A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q [J].

Fenaux, Pierre ;

Giagounidis, Aristoteles ;

Selleslag, Dominik ;

Beyne-Rauzy, Odile ;

Mufti, Ghulam ;

Mittelman, Moshe ;

Muus, Petra ;

Boekhorst, Peter Te ;

Sanz, Guillermo ;

del Canizo, Consuelo ;

Guerci-Bresler, Agnes ;

Nilsson, Lars ;

Platzbecker, Uwe ;

Luebbert, Michael ;

Quesnel, Bruno ;

Cazzola, Mario ;

Ganser, Arnold ;

Bowen, David ;

Schlegelberger, Brigitte ;

Aul, Carlo ;

Knight, Robert ;

Francis, John ;

Fu, Tommy ;

Hellstrom-Lindberg, Eva .

BLOOD, 2011, 118 (14) :3765-3776

[6] Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide [J].

Giagounidis, A. A. N. ;

Kulasekararaj, A. ;

Germing, U. ;

Radkowski, R. ;

Haase, S. ;

Petersen, P. ;

Goehring, G. ;

Buesche, G. ;

Aul, C. ;

Mufti, G. J. ;

Platzbecker, U. .

LEUKEMIA, 2012, 26 (04) :855-858

[7] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion [J].

List, Alan ;

Dewald, Gordon ;

Bennett, John ;

Giagounidis, Aristotle ;

Raza, Azra ;

Feldman, Eric ;

Powell, Bayard ;

Greenberg, Peter ;

Thomas, Deborah ;

Stone, Richard ;

Reeder, Craig ;

Wride, Kenton ;

Patin, John ;

Schmidt, Michele ;

Zeldis, Jerome ;

Knight, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1456-1465

[8] Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet [J].

Malcovati, Luca ;

Hellstrom-Lindberg, Eva ;

Bowen, David ;

Ades, Lionel ;

Cermak, Jaroslav ;

del Canizo, Consuelo ;

Della Porta, Matteo G. ;

Fenaux, Pierre ;

Gattermann, Norbert ;

Germing, Ulrich ;

Jansen, Joop H. ;

Mittelman, Moshe ;

Mufti, Ghulam ;

Platzbecker, Uwe ;

Sanz, Guillermo F. ;

Selleslag, Dominik ;

Skov-Holm, Mette ;

Stauder, Reinhard ;

Symeonidis, Argiris ;

van de Loosdrecht, Arjan A. ;

de Witte, Theo ;

Cazzola, Mario .

BLOOD, 2013, 122 (17) :2943-2964

← 1 →